Aurora: Investor Presentation

Aurora's Path to Profitability NEAR TERM • Drive down costs by leveraging massive scale Protecting against eventual margin compression • Leadership in Global Medical Markets • Invest heavily in R&D to create optionality Brand building and protection through high-quality product MEDIUM TERM • Harvest Canadian market cash flow from near-term domestic strategy Leverage R&D work in higher-margin products (Vapes, CBD infusions, etc.) Global Medical leading to higher-margin sales LONG TERM • Branded high-margin products across both global medical and consumer markets R&D supports product development, brand development, and continued improvement in yields AURORA 14

View entire presentation